Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt

• Sponsor: Assiut University (Other)
• Overall Status: Completed
• CT.gov ID: NCT04488588
• Collaborator: (none)
• Enrollment: 1,064
• Locations: 2
• Actual Duration (Months): 3.5
• Patients Per Site: 532
• Patients Per Site Per Month: 149.9

Study Details

Study Description

Brief Summary

Through history, there have been plenty of pandemics however; the social response to corona virus disease (COVID-19) is unparalleled. It is assessed that almost four billion individuals are living in social segregation during this mother of all pandemics.

Initially described in China in December 2019, severe acute respiratory syndrome caused by corona virus 2 (SARS-CoV-2) has spread all over the world and by 18th July 2020- there was an emergent figure of 13,824,739 confirmed cases and 591.666 losses reported to the WHO. To date, Egypt reported slightly over 82,000 confirmed COVID-19 cases with 3858 deaths. The new pandemic is injuring not only health organizations of several countries but also the financial prudence universal.

Defining the clinical features and associated outcomes of patients diagnosed with coronavirus disease (COVID-19) is fundamental to improving our understanding and adequate management of this illness. Several articles have recently been published, describing the clinical features and outcomes of retrospective individuals with COVID-19

Condition or Disease	Intervention/Treatment	Phase
Covid19; Coronavirus Disease; SARS-CoV-2	Other: Kaplan Meier analysis

Study Design

• Study Type: Observational
• Actual Enrollment: 1064 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Survival and 30-days Hospital Outcome in Hospitalized COVID-19 Patients in Upper Egypt: Multi-center Study
• Actual Study Start Date: Mar 15, 2020
• Actual Primary Completion Date: May 1, 2020
• Actual Study Completion Date: Jul 1, 2020

Outcome Measures

Primary Outcome Measures

1. number of co-morbidities in hospitalized patients with COVID-19 [one month]

   Determinants of survival in studied covid-19 patients admitted to hospitals

2. causes of ICU admission [one month]

   Determinants of ICU admission in hospitalized patients with COVID-19

Eligibility Criteria

Criteria

• Ages Eligible for Study: 36 Years to 63 Years
• Sexes Eligible for Study: All

Inclusion Criteria:

• This study included 1064 patients consecutively admitted to isolation hospitals in Upper Egypt during the period from 22 March to 23 June 2020

Exclusion Criteria:

• only hospitalized confirmed cases of COVID-19 were included.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	AssiutU	Assiut		Egypt	71111
2	Aliae Mohamed-Hussein	Assiut		Egypt	71515

Sponsors and Collaborators

• Assiut University

Investigators

• Principal Investigator: Aliae Mohamed-Hussein, MD, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Aliae AR Mohamed Hussein, Professor of Pulmonology, Assiut University
• ClinicalTrials.gov Identifier: NCT04488588
• Other Study ID Numbers: AssiutU17
• First Posted: Jul 28, 2020
• Last Update Posted: Jul 28, 2020
• Last Verified: Jul 1, 2020

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Aliae AR Mohamed Hussein, Professor of Pulmonology, Assiut University: COVID-19; Survival; 30- Days Hospital outcome; outcome
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Jul 28, 2020